Exploration of the value of MRCP combined with tumor marker CA19-9 in the diagnosis of pancreatic cancer
Source abstract
Abstract
This paper aims to provide an effective, accurate, and specific diagnostic method for the diagnosis of pancreatic cancer. It discusses the diagnostic value of magnetic res retrograde cholangiopancreatography (MRCP) combined with the detection of tumor marker carbohydrate antigen 19-9 (CA19-9) for pancreatic cancer. A group of confirmed cases of pancreatic cancer in some hospitals were randomly selected and subjected to an MRCP examination as well as serological CA19-9 detection. In addition, a group of patients whose pancreatic cancer was confirmed by surgery and pathology, and who underwent MRCP without the detection of the tumor marker CA19-9, were also selected for research. The experiment found that the rate of accuracy for the group that underwent MRCP combined with CA19-9 detection showed a higher positive value in the diagnosis of pancreatic cancer than in the group that underwent MRCP alone. Therefore, this paper proposes that MRCP combined with CA19-9 detection can be taken as the reliable and effective means for diagnosis of pancreatic cancer.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Pancreatic and Hepatic Oncology Research · Cholangiocarcinoma and Gallbladder Cancer Studies · Pediatric Hepatobiliary Diseases and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Oncology, Nankai Hospital, Tianjin, China
Department of Emergency Surgery, Nankai Hospital, Tianjin, China
Endoscopy Center, Nankai Hospital, Tianjin, China
Nankai Hospital, Nankai Clinical School, Tianjin Medical University, Tianjin, China
References (12)
Show source-provided references
1. 10.1245/s10434-010-0955-x10.1245/s10434-010-0955-x ↗
2. 10.2174/1381612811209243910.2174/13816128112092439 ↗
3. 10.1186/1476-4598-11-1910.1186/1476-4598-11-19 ↗
4. Guo RD · Chin J Hepato Sur · 2010 · 16 · 204
5. Lenz J · Gastrointestin Liver Dis · 2011 · 20 · 389
6. Liu J · Mod Prev Medi · 2014 · 41 · 531
7. Teng YP. · Shandong Medi J · 2011 · 51 · 70
8. 10.1016/S0140-6736(10)62307-010.1016/S0140-6736(10)62307-0 ↗
9. Wei JQ · Chin Pract Medi · 2010 · 5 · 50
10. 10.1097/PPO.0b013e318275680310.1097/PPO.0b013e3182756803 ↗
11. Yin LL · Medi J Beijing Military Region · 2013 · 25 · 31
12. Zhang Y. · J Prac Radi · 2008 · 24 · 919